METHOD FOR PRODUCING STEM CELLS WITH A SIZE SUITABLE FOR INTRAVASCULAR ADMINISTRATION (South Korea)
Culture media and methods for culturing mesenchymal stem cell (Europe, US, Australia)
Method for Isolating and Culturing Adult Stem Cells Derived from Human Amniotic Epithelium (Canada)
Method for isolation, expansion and differentiation of a hair follicle stem cell, and a composition for hair reproduction (Japan)
Patent Applications
MEDIUM COMPOSITION FOR MAKING STEM CELLS FRESH (Europe, US, Canada, Brazil, Australia, China, etc.)
METHOD AND COMPOSITION FOR PREVENTING DISRUPTION AND AGGREGATION OF STEM CELLS (Europe, US, Japan, China, India, Australia, etc.)
METHOD FOR PRODUCING STEM CELLS WITH A SIZE SUITABLE FOR INTRAVASCULAR ADMINISTRATION (Europe, US, China, Japan, etc.)
METHOD FOR PREPARING HIGH CONCENTRATION STEM CELLS (Europe, US, Brazil, Mexico, China, India, Japan, etc.)
COMPOSITION CONTAINING MESENCHYMAL STEM CELL CULTURE AND BASE FOR ENHANCING STEM CELL STABILITY (South Korea)
MEDIUM COMPOSITION FOR CULTURING STELL CELLS (South Korea)
2013
Developed a culturing technology for making stem cells fresh
Successfully developed a small autologous adipose stem cell maintenance and cultivation technology
Patent Registrations
COMPOSITION WHICH INDUCES ADIPOSE-DERIVED ADULT STEM CELL MIGRATION (South Korea)
Composition for Treating of Ischemic Limb Disease Comprising Stem Cells Derived from Adipose Tissue (Europe, Japan, China)
Celluar Therapeutic Agent for Incontinence of Urine Comprising Stem Cells Originated from Decidua (China, Japan)
METHOD FOR PROLIFERATING A LARGE AMOUNT OF HAIR FOLLICLE STEM CELLS (South Korea)
Method for Isolating and Culturing Adult Stem Cells Derived from Human Amniotic Epithelium (US, Japan)
Culture media and methods for culturing mesenchymal stem cell (South Africa)
Patent Applications
MEDIA COMPOSITION FOR IMPROVING RENEWAL ABILITY OF STEM CELLS AND METHOD FOR CULTURING STEM CELLS USING SAME (South Korea)
STEM CELL COMPOSITION FOR INTRAVENOUS ADMINISTRATION (South Korea)
Culture media and methods for culturing mesenchymal stem cell (Europe, US, Australia)
2012
Began the clinical research on the treatment of spinal cord injury
Signed a placental stem cell joint research agreement with Jeil Hospital
Provided gratuitous stem cell storage services for children with cerebral palsy
Signed a joint research and clincal test agreement with Science Academy Hospital, Russia
Signed a stem cell research agreement with Boramae Hospital, Seoul
Participated in RIO+20 Corporate Sustainability Forum, UN Global Compact (UNGC)
Held a presentation on overcoming rare and incurable diseases through adult stem cells and medical support for children with cerebral palsy
Case report on the treatment of cerebral palsy patients using adipose tissue derived stem cells
Paper published: the Effect and Stability of Autologus Derived Stem Cell Injection for Severe Lower Limb Ischemia Patients
Paper published: Clinical Application of Adipose Tissue Derived Stem Cells to Romberg’s Disease
Patent Registrations
Multipotent Stem Cell Derived from Human Adipose Tissue and Cellular Therapeutic Agents Comprising the Same (Vietnam)
Composition for Treating of Ischemic Limb Disease Comprising Stem Cells Derived from Adipose Tissue (Singapore)
Culture media and methods for culturing mesenchymal stem cell (South Korea)
2011
Paper published – Safety of Intravenous Injection of Stem Cells – Stem cell & Development
Paper published – Treatment for Autoimmune Patients using Stem Cells
Signed an MOU for construction of a stem cell regenerative medicine center in Osong Medical Complex (Chungcheongbukdo)
Patent Registrations
Multipotent Stem Cell Derived from Human Adipose Tissue and Cellular Therapeutic Agents Comprising the Same (31 countries in Europe, Singapore, UK, Australia, Russia, Japan)
Composition for Treating of Critical Limb Ischemia Disease Comprising Stem Cells Derived from Adipose Tissue (Mexico)
Celluar Therapeutic Agent for Incontinence of Urine Comprising Stem Cells Originated from Decidua (South Korea)
2010
Developed the technology for proliferating placenta-derived amniotic epithelial stem cells
Patent Registrations
Multipotent Stem Cell Derived from Human Adipose Tissue and Cellular Therapeutic Agents Comprising the Same (US)
2009
Spinal cord injury treatment using autologous adipose tissue derived stem cells passes commercial clinical test
Succeeded in treating a patient with malignant rheumatoid arthritis using autologous adipose tissue derived stem cells (1st time in the world)
Succeeded in treating a patient with auto immune disease using autologous adipose tissue derived stem cells (1st time in the world)
Succeeded in treating a patient with severe atopy using autologous adipose tissue derived stem cells (1st time in the world)
Case report on treatment of a chronic cerebral hemorrhage patient using autologous adipose tissue derived stem cells
Developed a technology for customized stem cell cosmetic products (1st time in the world)
Patent Registrations – Multipotent Stem Cell Derived from Human Adipose Tissue and Cellular Therapeutic Agents Comprising the Same (Germany) – Method for isolation, expansion and differentiation of a hair follicle stem cell, and a composition for hair reproduction (Germany)
2008
JointStem (degenerative arthritis medicine) passes clinical test (Phase 1, 2)
Romberg’s disease treatment using adipose stem cells passes researcher clinical test
Acquired a South Korean patent for a cord blood-derived stem cell technology (technology transfer from Seoul National University)
Urinary incontinence treatment using stem cells passes animal clinical test
Development of spinal cord injury medicine selected as a government-funded project
Patent Registrations
Multipotent Stem Cell Derived from Human Adipose Tissue and Cellular Therapeutic Agents Comprising the Same (South Korea)
Method for Isolating and Culturing Adult Stem Cells Derived from Human Amniotic Epithelium (South Korea)
Hair Restoration and Composition for Hair Restoration using Autologous Follicular Cells (South Korea)
2007
Berger’s disease treatment using autologous adipose tissue derived stem cells passes commercial clinical test (Phase 1, 2)
Completed the safety test for adipose stem cell (Clinical Medicine Institute, Seoul National University)
Signed an MOU for public development of stem cell medicine with Boramae Hospital
Patent Registrations
Multipotent Stem Cell Derived from Human Adipose Tissue and Cellular Therapeutic Agents Comprising the Same (South Korea)
Method for Culturing and Proliferating of Hematopoietic Cells Through Co-culture with Adult Stem Cells (South Korea)
Cosmetic or Plastic Composition Comprising Multipotent Stem Cells Derived from Human Adipose Tissue, Fibroblast and Adipose or Adipocyte
2006
Cosmetic or Plastic Composition Comprising Multipotent Stem Cells Derived from Human Adipose Tissue, Fibroblast and Adipose or Adipocyte
Began the pre-clinical trial for stem cell medicine for cranial deficiency – Seoul Asan Medical Center
Signed an MOU for collaboration for stem cell research – Johns Hopkins University, US
Separated placental stem cell for the first time in South Korea Cultivation successful
Successfully treated severe spinal cord injury using stem cells